Edition:
United Kingdom

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

1.02USD
20 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.02
Open
$1.01
Day's High
$1.06
Day's Low
$0.98
Volume
304,780
Avg. Vol
319,416
52-wk High
$12.27
52-wk Low
$0.66

Latest Key Developments (Source: Significant Developments)

Biocept Announces Pricing Of $7.5 Mln Underwritten Public Offering
Friday, 8 Feb 2019 

Feb 8 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF $7.5 MILLION UNDERWRITTEN PUBLIC OFFERING.BIOCEPT - EACH SHARE OF IS BEING SOLD TOGETHER WITH ONE WARRANT TO PURCHASE ONE SHARE AT A COMBINED PRICE TO PUBLIC OF $1.20 PER SHARE AND WARRANT.BIOCEPT INC - WARRANTS WILL BE IMMEDIATELY EXERCISABLE AT A PRICE OF $1.20 PER SHARE OF COMMON STOCK AND WILL EXPIRE FIVE YEARS FROM DATE OF ISSUANCE.  Full Article

Lincoln Park Capital Fund Llc Reports 9.99 Pct Passive Stake In Biocept Inc As Of September 20
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Biocept Inc ::LINCOLN PARK CAPITAL FUND LLC REPORTS 9.99 PERCENT PASSIVE STAKE IN BIOCEPT INC AS OF SEPTEMBER 20 - SEC FILING.  Full Article

Biocept Enters Into Agreement With Alliance Global FZ
Friday, 13 Jul 2018 

July 13 (Reuters) - Biocept Inc ::BIOCEPT ENTERS INTO AGREEMENT WITH ALLIANCE GLOBAL FZ TO MARKET AND DISTRIBUTE LIQUID BIOPSY TESTING IN THE MIDDLE EAST, SOUTHEAST ASIA, AND AFRICA REGION.BIOCEPT INC - ADDITIONAL TERMS OF AGREEMENT WERE NOT DISCLOSED..BIOCEPT - EXPANDS INTERNATIONAL DISTRIBUTION OF TARGET SELECTOR PLATFORM TO 17 COUNTRIES.  Full Article

Biocept Says Pursuant To Approval Of Co's Board, Co Effected A Reverse Stock Split Of Co's Common Stock
Friday, 6 Jul 2018 

July 6 (Reuters) - Biocept Inc ::BIOCEPT SAYS PURSUANT TO APPROVAL OF CO'S BOARD, CO EFFECTED A REVERSE STOCK SPLIT OF CO'S COMMON STOCK AT A RATIO OF 1:30 - SEC FILING.  Full Article

Biocept Inc Files For Mixed Shelf Of Up To $50 Million
Tuesday, 15 May 2018 

May 15 (Reuters) - Biocept Inc ::BIOCEPT INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING.  Full Article

Biocept Prices $15 Million Public Offering Of 33.3 Mln Shares and Warrants
Friday, 26 Jan 2018 

Jan 26 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF $15.0 MILLION PUBLIC OFFERING OF 33,333,333 SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE 33,333,333 SHARES OF COMMON STOCK.BIOCEPT INC - PRICING OF OFFERING OF UP TO 33.3 MILLION SHARES AND WARRANTS TO PURCHASE UP TO 33.3 MILLION SHARES OF COMMON STOCK AT COMBINED PRICE OF $0.45.  Full Article

Biocept Offers 18.8 Mln Shares Of Common Stock
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Biocept Inc ::BIOCEPT INC FILES TO SAY IT OFFERING 18.8 MILLION SHARES OF ITS COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK - SEC FILING.BIOCEPT INC - OFFERING AT AN ASSUMED COMBINED OFFERING PRICE OF $0.665 PER SHARE OF COMMON STOCK AND ACCOMPANYING WARRANTS.  Full Article

Biocept Inc Says Signed An In-Network Provider Agreement With Wellmark Inc
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Biocept Inc ::BIOCEPT INC - HAS SIGNED AN IN-NETWORK PROVIDER AGREEMENT WITH WELLMARK INC.  Full Article

Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC <<>> AS OF DEC 5 - SEC FILING.  Full Article

Biocept announces pricing of public offering of up to 4,925,936 shares of common stock
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 4,925,936 SHARES OF COMMON STOCK.BIOCEPT - ‍PRICED BEST EFFORTS REGISTERED PUBLIC OFFERING OF UP TO 4.9 MILLION SHARES OF CO'S COMMON STOCK AT PRICE TO PUBLIC OF $0.68/SHARE​.  Full Article

BRIEF-Biocept And Prognos Enter Into Partnership

* BIOCEPT AND PROGNOS ENTER INTO PARTNERSHIP TO APPLY ARTIFICIAL INTELLIGENCE IN ORDER TO HELP PHARMACEUTICAL AND LIFE SCIENCES COMPANIES OPTIMIZE COMMERCIALIZATION OF BIOMARKER-TARGETED THERAPIES IN ONCOLOGY Source text for Eikon: Further company coverage: